Kane Biotech, Inc. is a biotechnology company, which engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms. It operates through Domestic and International geographical segments. The firm's trademarks include StrixNB, DispersinB, Aledex, bluestem, silkstem, coactiv+, and Kan. The company was founded in 2001 and is headquartered in Winnipeg, Canada.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company